The overactive bladder treatment market has undergone significant transformation over the past decade, driven largely by advancements in pharmacological therapies and minimally invasive interventions. As patient expectations rise and tolerance for side effects declines, the industry is shifting toward safer, more effective, and patient-centric treatment solutions. Valued at US$...